<DOC>
	<DOCNO>NCT02424370</DOCNO>
	<brief_summary>Transcutaneous trans-aortic valve replacement ( TAVR ) common procedure treat symptomatic aortic stenosis . Although effective safe surgical aortic valve replacement , still restrict high surgical risk patient frail . The aim TAVI-EVA identify geriatric biomarkers may help predict survival functional recovery TAVR</brief_summary>
	<brief_title>Geriatric Evaluation Predict Mortality Functional Recovery After Trans Aortic Valve Implantation</brief_title>
	<detailed_description>Primary objective : identify geriatric biomarkers associate vital/functional status TAVR . Primary outcome measure alter functional status six month follow-up define absolute decrease 15 point Barthel Index . Secondary outcome measure : Barthel index survival 6 , 9 12 month follow-up . QOL follow-up</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Age â‰¥75 Symptomatic aortic stenosis Prior geriatric evaluation Patient agree answer telephone followup 6 , 9 12 month Patient give nonopposition use data Patient affiliate French social security . Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Aortic stenosis</keyword>
	<keyword>TAVR</keyword>
	<keyword>Frailty</keyword>
	<keyword>Elderly</keyword>
</DOC>